Unitedhealth Group Incorporated Stock Market Value
| UNH Stock | USD 347.75 9.32 2.75% |
| Symbol | UnitedHealth |
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of UnitedHealth Group. If investors know UnitedHealth will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about UnitedHealth Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.60) | Dividend Share 8.62 | Earnings Share 19.18 | Revenue Per Share | Quarterly Revenue Growth 0.122 |
The market value of UnitedHealth Group is measured differently than its book value, which is the value of UnitedHealth that is recorded on the company's balance sheet. Investors also form their own opinion of UnitedHealth Group's value that differs from its market value or its book value, called intrinsic value, which is UnitedHealth Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because UnitedHealth Group's market value can be influenced by many factors that don't directly affect UnitedHealth Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between UnitedHealth Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if UnitedHealth Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, UnitedHealth Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
UnitedHealth Group 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to UnitedHealth Group's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of UnitedHealth Group.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in UnitedHealth Group on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding UnitedHealth Group Incorporated or generate 0.0% return on investment in UnitedHealth Group over 90 days. UnitedHealth Group is related to or competes with Novartis, Abbott Laboratories, AstraZeneca PLC, Cigna Corp, Merck, Novo Nordisk, and Thermo Fisher. UnitedHealth Group Incorporated operates as a diversified health care company in the United States More
UnitedHealth Group Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure UnitedHealth Group's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess UnitedHealth Group Incorporated upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.07) | |||
| Maximum Drawdown | 7.02 | |||
| Value At Risk | (2.34) | |||
| Potential Upside | 2.7 |
UnitedHealth Group Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for UnitedHealth Group's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as UnitedHealth Group's standard deviation. In reality, there are many statistical measures that can use UnitedHealth Group historical prices to predict the future UnitedHealth Group's volatility.| Risk Adjusted Performance | (0.0004) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.05) |
UnitedHealth Group January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.0004) | |||
| Market Risk Adjusted Performance | (0.04) | |||
| Mean Deviation | 1.37 | |||
| Coefficient Of Variation | (12,141) | |||
| Standard Deviation | 1.7 | |||
| Variance | 2.89 | |||
| Information Ratio | (0.07) | |||
| Jensen Alpha | (0.07) | |||
| Total Risk Alpha | (0.24) | |||
| Treynor Ratio | (0.05) | |||
| Maximum Drawdown | 7.02 | |||
| Value At Risk | (2.34) | |||
| Potential Upside | 2.7 | |||
| Skewness | 0.2867 | |||
| Kurtosis | (0.20) |
UnitedHealth Group Backtested Returns
UnitedHealth Group owns Efficiency Ratio (i.e., Sharpe Ratio) of -0.0337, which indicates the firm had a -0.0337 % return per unit of risk over the last 3 months. UnitedHealth Group Incorporated exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate UnitedHealth Group's Risk Adjusted Performance of (0.0004), coefficient of variation of (12,141), and Variance of 2.89 to confirm the risk estimate we provide. The entity has a beta of 0.53, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, UnitedHealth Group's returns are expected to increase less than the market. However, during the bear market, the loss of holding UnitedHealth Group is expected to be smaller as well. At this point, UnitedHealth Group has a negative expected return of -0.059%. Please make sure to validate UnitedHealth Group's potential upside, as well as the relationship between the rate of daily change and period momentum indicator , to decide if UnitedHealth Group performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.31 |
Poor reverse predictability
UnitedHealth Group Incorporated has poor reverse predictability. Overlapping area represents the amount of predictability between UnitedHealth Group time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of UnitedHealth Group price movement. The serial correlation of -0.31 indicates that nearly 31.0% of current UnitedHealth Group price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.31 | |
| Spearman Rank Test | -0.28 | |
| Residual Average | 0.0 | |
| Price Variance | 53.83 |
Currently Active Assets on Macroaxis
When determining whether UnitedHealth Group offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of UnitedHealth Group's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Unitedhealth Group Incorporated Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Unitedhealth Group Incorporated Stock:Check out UnitedHealth Group Correlation, UnitedHealth Group Volatility and UnitedHealth Group Alpha and Beta module to complement your research on UnitedHealth Group. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
UnitedHealth Group technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.